Eupraxia Pharmaceuticals is trading 7.38% up now at $8.00 in after-hours trading, supported by broader healthcare-sector strength and a generally positive equity session.
- It gained 17.51% during the September 2, 2026 regular session.
- No clear company-specific announcement was identified for September 2.
- The latest releases were August clinical-response data and August 11 second-quarter results.